Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative therapeutics utilizing first-in-disease approaches targeting neuroscience-based conditions with high unmet need. Noema has four programs currently in active Phase 2 clinical trials evaluating pain in ...

more

Alentis Therapeutics is developing breakthrough treatments for fibrotic disease and associated cancers. We are putting the brakes on fibrosis and aim to change the course of a disease associated with 45% of deaths in the developed world. Our unique approach is to develop highly selective ...

more